Drug treatment for hypertension
271 results
201 - 271
New oral analogue to remdesivir is similarly effective to nirmatrelvir-ritonavir for mild to moderate symptomatic COVID-19- Sibutramine increases risk of CV events and is not effective for weight loss
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review- Drugs for treatment of very high blood pressure during pregnancy
Chronic diseases and pregnancy - Time course for blood pressure lowering of dihydropyridine calcium channel blockers: Cochrane systematic review
- Stem cell transplantation for systemic sclerosis
- Effect of atorvastatin on testosterone levels
- Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Interventions in the treatment and prevention of obesity
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Normotensive patients at intermediate risk of CV disease do not benefit from ARB + HCTZ (HOPE-3)
- Acute kidney injury
- Urinary incontinence in women
- Combined diet and exercise interventions for preventing gestational diabetes mellitus
- Controlled-release combo of phentermine and topiramate decreases weight (CONQUER)
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension: Cochrane systematic review
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants
- Cefepime/taniborbactam is superior to meropenem for microbiologic, but not clinical, cures of complicated UTI (CERTAIN-1 study)
- Multimorbidity
- Interventions for improving adherence to ocular hypotensive therapy
- Pharmacological interventions for apathy in Alzheimer's disease
- Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation
- Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension: Cochrane systematic review
- British Society for Rheumatology Guideline for managing patients with gout
- Use of medication during pregnancy
- Epidural therapy for the treatment of severe pre‐eclampsia in non labouring women
- Balneotherapy for chronic venous insufficiency
- Statins for the primary prevention of cardiovascular disease
- Chronic heart failure
- Preoperative assessment
- Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Falls of the elderly
- Implantable cardioverter-defibrillator (ICD)
- Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients
- Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
- Different antihypertensive agents as first line therapies
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: Cochrane systematic review
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings
- Fludrocortisone for orthostatic hypotension
- Different intensities of glycaemic control for women with gestational diabetes mellitus
- Drugs for treating Schistosoma mansoni infection
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- Interventions for reducing inflammation in familial Mediterranean fever
- Prevention of venous thromboembolism
- Treatment of dyslipidaemias
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
- PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
- Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
- Active versus expectant management for women in the third stage of labour
- Pharmacological interventions for painful sickle cell vaso‐occlusive crises in adults
- Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes
- Thrombolytic therapy for pulmonary embolism
- Topical clonidine for neuropathic pain in adults
- Oral aspirin for treating venous leg ulcers
- Acute coronary syndrome
- ACE inhibitors and angiotensin receptor blockers for progression of non-diabetic renal disease
- Antenatal clinics: care and examinations
- Anti‐angiogenic therapy for high‐grade glioma
- Lifestyle education in type 2 diabetes
- Treatment of chronic renal failure
- Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
- Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews
- Impaired vision